Skip to content
Home
About us
Careers
Investors
Media
Partnering
Products
Research
Responsibility
Contact us
Welcome to AstraZeneca's international website.
As one of the world's leading pharmaceutical companies, our business is focused on turning good ideas into innovative, effective medicines that make a real difference in important areas of healthcare.
Latest news
20 November 2008
:
AstraZeneca to divest Nordic over-the-counter portfolio
20 November 2008
:
AstraZeneca to Realign Supply Chain to Improve Productivity and Move Closer to Customers
20 November 2008
:
AstraZeneca granted Temporary Restraining Order in PULMICORT RESPULES patent litigation
Features
9 November 2008:
Crestor JUPITER study results
Read more about our new Code of Conduct, which reflects our continued commitment to doing business the right way.
AstraZeneca websites
Search
Advanced search
Quick links
MedImmune
Jobs
Key facts
Key products
Clinical trials information
2007 annual report
Worldwide locations
Site map
Information for
Patients and families
Healthcare professionals
US visitors
Visit our US website
Share price
London
24.59
GBP
New York
34.49
USD
Stockholm
301.00
SEK
Updated 01:49 GMT 21 Nov 08
AstraZeneca news feed
Subscribe via RSS
Terms of use
Privacy policy
© AstraZeneca PLC 2003 - 2008